During the past decade, Preventive Cardiology Inc. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Preventive Cardiology Inc." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Preventive Cardiology Inc." are "Heart Failure" (2 trials), "Dyslipidemias" (1 trials), "Hypercholesterolemia" (1 trials), "Mixed Dyslipidemia" (1 trials) and "Severe Hypertriglyceridemia" (1 trials). Many other conditions were trialed in "Preventive Cardiology Inc." in a lesser frequency.

Most popular intervention types in "Preventive Cardiology Inc." are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "ARO-APOC3" (3 trials), "Empagliflozin" (2 trials), "Background Lipid Modifying Therapy (LMT)" (1 trials) and "Evinacumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Preventive Cardiology Inc." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Preventive Cardiology Inc.". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Preventive Cardiology Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Preventive Cardiology Inc., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".